NCT04269668View on ClinicalTrials.gov

An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Glycemic Control Using Hybrid-closed Loop vs. Advanced Hybrid Closed-loop in Young Subjects With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 19, 2020

Primary Completion Date

February 20, 2021

Study Completion Date

March 20, 2021

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

Medtronic Minimed 670G 3.0 HCL

Hybrid closed loop system

DEVICE

Medtronic Minimed 670G 4.0 AHCL

Advanced hybrid closed loop system

Trial Locations (2)

4920235

Schneider Children's Medical Center of Israel, Petah Tikva

Unknown

Diabetes -Zentrum fuer kinder und jugendliche, Hanover

Sponsors

Collaborators (1)

Medtronic
All Listed Sponsors
collaborator

GIF

UNKNOWN

collaborator

Medtronic

INDUSTRY

lead

Rabin Medical Center

OTHER

NCT04269668 - An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Glycemic Control Using Hybrid-closed Loop vs. Advanced Hybrid Closed-loop in Young Subjects With Type 1 Diabetes | Biotech Hunter | Biotech Hunter